Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer

BMC Cancer

Table 1 O-GlcNAcylation and expression of OGT according to clinicopathological parameters in bladder cancer (*P < 0.05; **P < 0.01)

Characteristic		O-GlcNAcylation score	OGT score	P value of O-GlcNAcylation	P value of OGT
Gender	male(126)	68.12 ± 44.01	107.32 ± 37.57	0.258	0.576
	female(43)	63.32 ± 38.14	103.32 ± 40.47
Age (y)				0.379	0.608
	< 65(84)	64.14 ± 41.99	108.77 ± 34.26
	≥65(85)	69.38 ± 43.10	104.09 ± 41.58
Body mass index (kg/m2)				0.022*	0.001**
	< 24.7(84)	59.19 ± 42.12	96.20 ± 41.00
	≥.001(85)	74.52 ± 41.79	116.29 ± 32.59
T stage				< 0.01**	0.005*
	NMIBC(85)	50.18 ± 37.37	99.51 ± 36.53
	MIBC(84)	83.82 ± 40.89	113.18 ± 38.93
Lymph node metastasis				0.630	0.019
	NO(83)	68.04 ± 42.17	112.60 ± 36.48
	YES(86)	65.80 ± 43.10	100.23 ± 39.13
pathology grade				0.742	0.335
	LOW(59)	68.26 ± 45.69	100.32 ± 44.24
	HIGH(110)	66.17 ± 40.93	109.52 ± 34.41
M stage				0.826	0.243
	NO(80)	66.19 ± 40.52	102.38 ± 38.65
	YES(89)	67.54 ± 44.48	109.84 ± 37.75

ISSN: 1471-2407